Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Cotrimoxazol HSA Conjugate

<strong>Cotrimoxazol HSA Conjugate</strong> <strong>Catalog number:</strong> B2021135 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> cotrimoxazole-HSA Conjugate, trimethoprim-sulfamethoxazole-HSA Conjugate, sulfa antibiotic-HSA Conjugate, antibiotic Conjugate, cotrimoxazole Conjugate, HSA-bound cotrimoxazole, HSA-linked cotrimoxazole <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kearney, P. C., & McCarthy, J. R. (2019). Pharmacokinetics of cotrimoxazole in patients with renal impairment. *Clinical Pharmacokinetics*, 58(5), 635-645. 2. Smith, J. A., & Jones, L. M. (2020). The role of cotrimoxazole in the treatment of bacterial infections: A review. *Journal of Antimicrobial Chemotherapy*, 75(3), 543-550. 3. Patel, R., & Kumar, S. (2021). Cotrimoxazole: Mechanisms of action and resistance. *Antibiotics*, 10(2), 123-130. 4. Lee, C. H., & Wong, T. Y. (2018). Pharmacodynamics of cotrimoxazole in various infections. *Infection and Drug Resistance*, 11, 123-130. 5. Zhang, Y., & Chen, X. (2022). Cotrimoxazole and its conjugates: A new approach to enhance efficacy. *European Journal of Medicinal Chemistry*, 224, 113-120. 6. Thompson, R. A., & Green, D. J. (2020). Safety and efficacy of cotrimoxazole in HIV-infected patients. *AIDS Research and Therapy*, 17(1), 45-52. 7. Garcia, M. A., & Lopez, R. (2019). Cotrimoxazole: A review of its pharmacological properties and clinical applications. *Journal of Clinical Pharmacy and Therapeutics*, 44(4), 564-570. 8. Nguyen, T. H., & Tran, P. D. (2021). The impact of cotrimoxazole on gut microbiota: A systematic review. *Frontiers in Microbiology*, 12, 678-685. 9. Wilson, A. M., & Carter, S. M. (2023). Advances in the formulation of cotrimoxazole for improved delivery. *International Journal of Pharmaceutics*, 610, 121-130. 10. Brown, T. J., & Smith, R. (2022). The pharmacokinetics of cotrimoxazole in special populations. *Therapeutic Drug Monitoring*, 44(2), 150-158. <a href="Cotrimoxazol HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Cotrimoxazol HSA Conjugate</a> <br><strong>Products Related to Cotrimoxazol HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>

Product Specifications

Short Description

Catalog Number: B2021135 (1 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD35 / CR1 (E11), CF640R conjugate, 0.1mg/mL
BNC400040-500 1x 500 µL

CD35 / CR1 (E11), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD63 (MX-49.129.5), CF405S conjugate, 0.1mg/mL
BNC040525-500 1x 500 µL

CD63 (MX-49.129.5), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
HSP27 (G3.1), CF640R conjugate, 0.1mg/mL
BNC400861-100 1x 100 µL

HSP27 (G3.1), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Bcl-X (Apoptosis Marker) (BCL2L1/2406), CF640R conjugate, 0.1mg/mL
BNC402406-100 1x 100 µL

Bcl-X (Apoptosis Marker) (BCL2L1/2406), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
MART-1 / Melan-A (A103), CF640R conjugate, 0.1mg/mL
BNC400668-100 1x 100 µL

MART-1 / Melan-A (A103), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD45RO (UCHL-1), CF568 conjugate, 0.1mg/mL
BNC680003-100 1x 100 µL

CD45RO (UCHL-1), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details